文献速递前列腺癌

同步与独立阅读前列腺特异性膜抗原正电子发射断层扫描(PSMA-PET)和磁共振成像(MRI)以提高前列腺癌诊断

Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.
PubMed 文献 · BJU Int · 2022-12-05

该回顾性分析从PRIMARY试验随机选取100例患者,由三名双培训医师独立及同步阅读mpMRI与68Ga-PSMA-11 PET/CT。同步阅读较单独mpMRI或PSMA-PET提高敏感性(93% vs 80% vs 88%),但特异性未改善(63% vs 58% vs 78%)。同步阅读与独立阅读后综合的诊断性能无显著差异。

要点

  • 同步阅读mpMRI/PSMA-PET的敏感性为93%,高于单独mpMRI的80%和单独PSMA-PET的88%。
  • 同步阅读的特异性为63%,单独mpMRI为58%,单独PSMA-PET为78%,特异性未改善。
  • 同步阅读与独立阅读后综合的诊断性能无显著差异。

核心结论

  • 同步阅读mpMRI/PSMA-PET较单独mpMRI或PSMA-PET提高了阅读者确定性和csPCa敏感性。
  • 独立阅读PSMA-PET和mpMRI报告后综合提供的诊断性能与同步PSMA-PET/MRI阅读相似。

研究设计与样本

  • 回顾性分析,从PRIMARY试验(前瞻性II期多中心影像试验)随机选取100例患者。
  • 三名双培训放射科/核医学医师以随机顺序、盲法对同一患者的mpMRI和PSMA-PET进行独立和同步重报。

主要发现

  • 活检显示国际泌尿病理学会分级组≥2癌症占60%。
  • 同步阅读mpMRI/PSMA-PET敏感性93%,单独mpMRI 80%,单独PSMA-PET 88%。
  • 同步阅读特异性63%,单独mpMRI 58%,单独PSMA-PET 78%。
  • 同步阅读与独立阅读后综合的诊断性能无显著差异。
  • 影像一致( Concordant)患者占60%,仅不一致病变占28%,混合(一致和不一致病变)占12%;当mpMRI/PSMA-PET一致且阳性时,95%患者有临床显著前列腺癌(csPCa)。

临床怎么用

  • 同步mpMRI/PSMA-PET阅读可能为泌尿科医生在转诊模式上提供更大灵活性,降低医疗系统成本并提高前列腺癌诊断效率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify whether synchronous reading of multiparametric magnetic resonance imaging (mpMRI) and 68 Ga-PSMA-11 positron emission tomography (PET)/computed tomography (prostate-specific membrane antigen [PSMA-PET]) images can improve diagnostic performance and certainty compared with mpMRI/PSMA-PET reported independently and synthesized, while also assessing concordance between imaging modalities and agreement with histopathology. METHODS: This was a retrospective analysis of 100 patients randomly selected from the PRIMARY trial, a prospective Phase II multicentre imaging trial. Three dual-trained radiologist/nuclear medicine physicians re-reported the mpMRI and PSMA-PET both independently and synchronously for the same patients in random order, blinded to previous results. Diagnostic performance was assessed for mpMRI/PSMA-PET images read synchronously or independently and then synthesized. Agreement between imaging results and histopathology was examined. 'Concordance' between imaging modalities was defined as overlapping lesions. Reporting certainty was evaluated by the individual reporters for each modality. RESULTS: International Society of Urological Pathology Grade Group ≥2 cancer was present in 60% of patients on biopsy. Synchronous reading of mpMRI/PSMA-PET increased sensitivity compared to mpMRI or PSMA-PET alone (93% vs 80% vs 88%, respectively), although specificity was not improved (63% vs 58% vs 78%, respectively). No significant difference in diagnostic performance was noted between mpMRI/PSMA-PET read synchronously and mpMRI or PSMA-PET reported independently and then synthesized. Most patients had concordant imaging (60%), while others had discordant lesions only (28%) or a mixture (concordant and discordant lesions; 12%). When mpMRI/PSMA-PET findings were concordant and positive, 95% of patients had clinically significant prostate cancer (csPCa). When PSMA-PET alone was compared to synchronous PSMA-PET/MRI reads, there was an improvement in reader certainty in 20% of scans. CONCLUSION: Synchronous mpMRI/PSMA-PET reading improves reader certainty and sensitivity for csPCa compared to mpMRI or PSMA-PET alone. However, synthesizing the results of independently read PSMA-PET and mpMRI reports provided similar diagnostic performance to synchronous PSMA-PET/MRI reads. This may provide greater flexibility for urologists in terms of referral patterns, reducing healthcare system costs and improving efficiencies in prostate cancer diagnosis.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Doan P, Counter W, Papa N, et al. Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer. BJU Int. 2022. PMID: 36371669. doi:10.1111/bju.15929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。